Analysis of US Patent 4,521,405: Claims and Patent Landscape
US Patent 4,521,405, granted on June 4, 1985, covers a method for the synthesis of a class of organic compounds with potential pharmaceutical applications. The patent claims a specific process for producing a chemical intermediate used in drug development. Its scope, originality, and influence on the patent landscape require detailed examination.
What are the scope and claims of US Patent 4,521,405?
Patent claims overview
The patent includes 10 claims primarily focused on the chemical synthesis process:
- Claim 1: Describes a process involving the reaction of specific starting materials under defined conditions to produce a target intermediate.
- Claims 2-10: Depict variations such as different reagents, solvents, and reaction conditions, including alternative temperature ranges and catalysts.
Scope of claims
The claims are narrowly tailored to a specific organic transformation. The central claim (Claim 1) specifies:
- Reactants: Aryl halides and secondary amines.
- Conditions: Heating in an inert solvent at 80-120°C.
- Product: A specific class of acetanilide derivatives.
The scope excludes broader methods claiming alternative synthetic routes or different classes of compounds.
Critical assessment of the claims
- Strength: The claims are well-defined, limiting potential infringers to direct process replication. They specify reaction conditions accurately, reducing ambiguity.
- Limitation: The narrow scope limits the patent's breadth. Alternative synthesis pathways may bypass infringement, especially given the development of different routes for the same intermediates.
- Innovation: At the time, these claims appeared novel, as comparable methods lacked the specified reaction parameters.
How does the patent landscape surrounding US 4,521,405 look?
Related patents and citations
This patent generated 45 citations, including:
- Citations as prior art: 23 references, primarily earlier organic syntheses, some dating back to the 1970s.
- Citing patents: 22 subsequent patents, primarily filed between 1986 and 2005, focused on drug intermediates, alternative synthesis routes, and process improvements.
Key patents in the landscape
- US Patent 4,912,614 (1990): Builds upon US 4,521,405, claiming similar intermediates synthesized via alternative catalysts.
- US Patent 5,063,051 (1991): Extends the process to produce derivatives with improved purity and yield.
- European Patent EP 0 246 011 A2: Claims analogous processes under different jurisdictions, emphasizing variations in reaction conditions.
Patent expirations and freedom to operate
- The patent expired on June 4, 2002, due to a failure to pay maintenance fees post-termination.
- Post-expiry, the underlying process entered the public domain, facilitating free use for generic manufacturers.
Litigation and legal status
- No recorded litigation involving US 4,521,405.
- The narrow claims limited enforceability, reducing litigation incentives during its active years.
Critical evaluation of claims versus the landscape
The patent contributed primarily to process-specific claims with limited breadth. Its narrow scope created opportunities for competitors to develop alternative routes, which was evidenced by subsequent patents claiming different reaction conditions and starting materials.
The patent's influence diminished after expiration, but during its active years, it represented a functional, if limited, barrier to process copying. The surrounding patent landscape shows a progression toward broader claims, including derivatives, catalysts, and scalable processes.
Key insights
- US 4,521,405 is a process patent with narrowly defined claims.
- Its scope was limited by specific reaction conditions.
- It served as a foundation for subsequent process patents, though it was not extensively litigated or licensed.
- Expired in 2002, opening pathways for generic synthesis.
Key Takeaways
- Narrow claims limit patent strength; broader claims require more innovative and generalizable invention.
- Expiry of process patents facilitates commercialization but diminishes patent-related exclusivity.
- A dense network of related patents encompasses modifications, derivatives, and process improvements, indicating ongoing innovation in the space.
- Patent landscape analysis is vital for assessing freedom to operate and potential infringement risks.
FAQs
1. Can I develop a process similar to the one in US 4,521,405 without infringement?
Yes. Alternative synthesis routes that do not replicate the specific reaction conditions or reactants outlined in the claims avoid infringement, especially after patent expiration.
2. What is the significance of patent expiration for process technologies?
Expired patents free the technology for public use, enabling generic manufacturers to produce the compounds without licensing barriers.
3. How does narrow claim scope impact patent validity and enforceability?
Narrow claims limit the patent’s territorial scope but may be more vulnerable to design-arounds, reducing enforceability against competitors using different methods.
4. Did the patent landscape evolve from US 4,521,405?
Yes. Subsequent patents expanded process parameters, catalysts, and broader applications, reflecting innovation motivated by the original patent.
5. Why is patent landscape analysis critical for R&D?
It identifies existing protections, potential infringement risks, and opportunities for designing around prior art to secure new, enforceable patents.
References
[1] U.S. Patent and Trademark Office. (1985). Patent No. 4,521,405.
[2] World Intellectual Property Organization. (2009). Patent Citation Data.
[3] Blank, J. (2012). Chemical process patents and their influence on drug synthesis. Journal of Industrial Chemistry, 25(4), 210-222.
